Journal Information

Statistics

Follow this link to access the full text of the article

Brief Communication
Real-life efficacy and safety of omalizumab in Portuguese patients with persistent uncontrolled asthma
M. Pereira Barbosaa, A. Bugalho de Almeidab, C. Pereirac,
Corresponding author
catarina.pereira@novartis.com

Corresponding author.
, C.-W. Chend, P. Georgioue, G. Peacheye, on behalf of eXpeRience study group
a Serviço de Imunoalergologia, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal
b Clínica Universitária de Pneumologia, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
c Novartis Farma – Produtos Farmaceuticos S.A., Avenida Professor Doutor Cavaco Silva, n.° 10E, Taguspark, 2740-255 Porto Salvo, Portugal
d Novartis Pharmaceuticals Corporation, One Health Plaza East Hanover, NJ 07936-1080, USA
e Novartis Pharmaceuticals UK Limited, Wimblehurst Road Horsham, West Sussex RH12 5AB, UK
Read
1047
Times
was read the article
536
Total PDF
511
Total HTML
Share statistics
Article information
ISSN: 21735115
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 20 28 48
2024 October 24 29 53
2024 September 27 24 51
2024 August 39 51 90
2024 July 28 30 58
2024 June 30 20 50
2024 May 33 35 68
2024 April 28 24 52
2024 March 34 23 57
2024 February 27 30 57
2024 January 18 18 36
2023 December 17 28 45
2023 November 21 25 46
2023 October 17 44 61
2023 September 20 28 48
2023 August 18 19 37
2023 July 22 26 48
2023 June 15 13 28
2023 May 43 29 72
2023 April 30 12 42
Show all

Follow this link to access the full text of the article

Pulmonology

Are you a health professional able to prescribe or dispense drugs?